Skip to content

AC Deflation in Descemet's Membrane Detachment

Effect of Anterior Chamber Deflation Before Reduction of a Detached Descemet's Membrane

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07364708
Enrollment
50
Registered
2026-01-23
Start date
2025-07-20
Completion date
2026-02-01
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Descemet's Membrane Disorder

Brief summary

using a relatively new technique to manage post-cataract surgery complication and measuring its efficacy

Interventions

PROCEDUREgroup A will undergo direct intracameral air injection and group B will undergo anterior chamber deflation then intracameral air injection

a group will undergo direct intracameral air injection and another group will undergo anterior chamber deflation then intracameral air injection

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with post cataract surgery DM detachment diagnosed within 1st week postoperatively. * Patient age ranges from 50 to 70 years old.

Exclusion criteria

* Less than one third of Descemet's Membrane is included. * Post-operative infection or severe inflammation. * Patient with pre-existing glaucoma.

Design outcomes

Primary

MeasureTime frame
Rate of complete anatomical reduction of DMD on ASOCT at the 1-week visit.1 week

Secondary

MeasureTime frame
. Time to complete anatomical reduction (days)1 month

Countries

Egypt

Contacts

CONTACTAhmed Maher Khalafallah
drahmedmaher1988@gmail.com+201119094426

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026